ABBOTT LABORATORI…
USUSDABBOTT LABORATORIES (US:ABT) — Biotechnology: Pharmaceutical Preparations. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 4. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.
À propos de l'entreprise
- Site Web
- abbott.com
- Secteur
- Health Care · Biotechnology: Pharmaceutical Preparations
- Siège Social
- North Chicago, United States
- PDG
- Robert Ford
- Employés
- 73 000
- Fondée
- 1888
- Actions en Circulation
- 1.73 Md au 2026-06-30
- Flottant
- 1.72 Md
- Capitalisation Boursière
- 169.83 Md USD
- Initiés
- 0.49%
- Investisseurs Institutionnels
- 81.79%
- Secteur d'Activité (SIC)
- Pharmaceutical Preparations
- Forme Juridique
- AZUK
- ISIN
- US0028241000
- LEI
- HQD377W2YR662HK5JX27
- P/E
- 33.6
- Taux de Distribution
- 66.7%
- FCF
- 7.38 Md USD
- Versements / FCF
- 57%
- Dette
- 34.0 Md USD3.7 ans de FCF
- Ancienneté du Dividende
- 43 ans
- Bénéfices, FCF et dividendes versés — pour les 12 mois précédant 31.03.2026 (le dernier rapport de l'entreprise).
- NAV
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Bourses et Tickers
Dividendes
ABBOTT LABORATORIES (ABT) verse des dividendes trimestriels. Par an (12 mois jusqu'au dernier paiement annoncé inclus) : 2.52 USD par action (paiements : 4). Cela représente environ 2.41% du cours actuel de l'action. D'après l'historique des paiements, la prochaine date ex-dividende est prévue vers 14.01.2027. Historique des dividendes ininterrompu : 43 ans.
| Date Ex | Versement | Montant | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-10-15 | 2026-11-16 | 0.6300 USD | 0.6/2.4 % | trimestriel | US:ABT |
| 2026-07-15 | 2026-08-17 | 0.6300 USD | 0.7/2.8 % | trimestriel | US:ABT |
| 2026-04-15 | 2026-05-15 | 0.6300 USD | 0.6/2.4 % | trimestriel | US:ABT |
| 2026-01-15 | 2026-02-13 | 0.6300 USD | 0.5/1.9 % | trimestriel | US:ABT |
| 2025-10-15 | 2025-11-17 | 0.5900 USD | 0.4/1.8 % | trimestriel | US:ABT |
| 2025-07-15 | 2025-08-15 | 0.5900 USD | 0.4/1.8 % | trimestriel | US:ABT |
| 2025-04-15 | 2025-05-15 | 0.5900 USD | 0.5/1.8 % | trimestriel | US:ABT |
| 2025-01-15 | 2025-02-14 | 0.5900 USD | 0.5/2.0 % | trimestriel | US:ABT |
| 2024-10-15 | 2024-11-15 | 0.5500 USD | 0.5/1.9 % | trimestriel | US:ABT |
| 2024-07-15 | 2024-08-15 | 0.5500 USD | 0.5/2.0 % | trimestriel | US:ABT |
| 2024-04-12 | 2024-05-15 | 0.5500 USD | 0.5/≈2.0 % | trimestriel | US:ABT |
| 2024-01-11 | 2024-02-15 | 0.5500 USD | 0.5/≈1.9 % | trimestriel | US:ABT |
| 2023-10-12 | 2023-11-15 | 0.5100 USD | 0.6/≈2.2 % | trimestriel | US:ABT |
Actualités de Cette Semaine
Communiqués de presse du site de l'entreprise pour les investisseurs, mis à jour chaque jour. Les liens mènent au site de l'entreprise. Les titres sont dans la langue originale, comme sur le site web de l'entreprise.
| 13.10.2026 | Newsroom | Top Stories |
| 12.10.2026 | Newsroom | Top Stories |
Principaux Actionnaires
| Détenteur | Participation | Actions | Date du Rapport |
|---|---|---|---|
| BlackRock | 8.82% | 152.56 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.57% | 113.75 M | 2026-06-30 |
| State Street Corporation | 4.68% | 80.93 M | 2026-06-30 |
| Charles Schwab Investmen… | 3.45% | 59.67 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.2% | 55.3 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.83% | 49.02 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.61% | 45.14 M | 2026-06-30 |
| Geode Capital Management… | 2.27% | 39.22 M | 2026-06-30 |
| Capital Research Global… | 2.13% | 36.91 M | 2026-06-30 |
| Capital International In… | 2% | 34.65 M | 2026-06-30 |
| SCHWAB STRATEGIC TRUST-S… | 1.9% | 32.82 M | 2026-05-31 |
| Morgan Stanley | 1.54% | 26.61 M | 2026-06-30 |
| NORGES BANK | 1.35% | 23.35 M | 2026-06-30 |
| iShares Trust-iShares Co… | 1.34% | 23.2 M | 2026-08-31 |
| Fidelity Concord Street… | 1.3% | 22.52 M | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 21.31 M | 2026-08-31 |
| WASHINGTON MUTUAL INVEST… | 1.01% | 17.53 M | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 0.96% | 16.58 M | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 12.52 M | 2026-08-31 |
| Investment Co of America | 0.6% | 10.33 M | 2026-06-30 |
| STARKS DANIEL J (Directo… | ≈0.39% | 6.75 M | 2026-04-27 |
| FORD ROBERT B. (Chief Ex… | ≈0.03% | 522 664 | 2026-08-25 |
| ALLEN HUBERT L. (Officer… | ≈0.01% | 200 281 | 2025-02-25 |
| SALVADORI DANIEL GESUA S… | ≈0.01% | 146 377 | 2026-03-02 |
| CONROY KEVIN T (Director… | ≈0.01% | 133 737 | 2026-04-24 |
| MORELAND MARY K (Officer… | ≈0.01% | 116 136 | 2026-03-02 |
| EARNHARDT LISA D (Office… | ≈0.01% | 98 984 | 2026-02-24 |
| SCOGGINS CHRISTOPHER J (… | ≈0% | 82 123 | 2026-02-24 |
| WAINER ANDREA F (Officer… | ≈0% | 74 381 | 2025-03-03 |
| The Vanguard Group | — | — | — |
| BOUDREAU PHILIP P (Chief… | — | — | 2026-04-23 |
